Dashboard
Manage Tickers

NSPR InspireMD, Inc.

Nasdaq inspiremd.com


$ 2.35 $ 0.02 (0.86 %)    

Monday, 20-Oct-2025 15:53:30 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.11 $ 7.61 (1.26 %)
DIA $ 467.12 $ 5.24 (1.13 %)
SPY $ 671.75 $ 6.91 (1.04 %)
TLT $ 91.68 $ 0.35 (0.38 %)
GLD $ 401.36 $ 14.16 (3.64 %)
$ 2.34
$ 2.33
$ 2.32 x 1,000
$ 2.36 x 176
-- - --
$ 1.99 - $ 3.80
32,081
na
97.63M
$ 0.73
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-12-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-05-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-05-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-07-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-08-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-10-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-05-2019 06-30-2019 10-Q
26 05-13-2019 03-31-2019 10-Q
27 02-19-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-06-2018 06-30-2018 10-Q
30 05-07-2018 03-31-2018 10-Q
31 02-13-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 02-16-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-28-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

inspiremd-q2-2025-eps-026-misses-025-estimate-sales-1778m-miss-1800m-estimate
InspireMD Q2 2025 EPS $(0.26) Misses $(0.2...
08/05/2025 12:01:29

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/01/2025 21:06:34

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/31/2025 17:08:07

inspiremd-announces-it-has-raised-58m-in-gross-proceeds-through-pipe-financing
InspireMD Announces It Has Raised ~$58M In...
07/31/2025 12:36:29

inspiremd-announces-us-commercial-launch-of-cguard-prime-carotid-stent-system-for-stroke-prevention
InspireMD Announces US Commercial Launch O...
07/09/2025 11:01:51

clinical-results-of-double-layer-micronet-stents-in-complex-anatomy--science-direct
'Clinical Results of Double-Layer MicroNet...
07/07/2025 18:30:26

https://www.sciencedirect.com/science/article/abs/pii/S0890509625004200

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/25/2025 12:09:37

why-blackberry-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why BlackBerry Shares Are Trading Higher B...
06/25/2025 09:43:37

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/24/2025 21:06:13

inspiremd-receives-fda-premarket-application-approval-for-cguard-prime-carotid-stent-system
InspireMD Receives FDA Premarket Applicati...
06/24/2025 20:06:46

InspireMD, Inc. (the "Company") (NASDAQ:NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of...

inspiremd-receives-ce-mark-approval-under-european-medical-device-regulation-for-cguard-prime-eps
InspireMD Receives CE Mark Approval Under ...
06/13/2025 13:01:39

inspiremd-appoints-michael-lawless-as-cfo-effective-june-30-2025
InspireMD Appoints Michael Lawless As CFO,...
06/03/2025 20:14:34

piper-sandler-maintains-overweight-on-inspiremd-lowers-price-target-to-4
Piper Sandler Maintains Overweight on Insp...
05/12/2025 17:56:01

Piper Sandler analyst Adam Maeder maintains InspireMD (NASDAQ:NSPR) with a Overweight and lowers the price target from $4.5 ...

inspiremd-q1-eps-022-misses-020-estimate-sales-153m-beat-145m-estimate
InspireMD Q1 EPS $(0.22) Misses $(0.20) Es...
05/09/2025 11:02:14

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) b...

Core News & Articles
Earnings Scheduled For May 9, 2025
05/09/2025 08:32:15

a-look-ahead-inspiremds-earnings-forecast
A Look Ahead: InspireMD's Earnings Forecast
05/08/2025 18:01:49

inspiremd-q4-2024-gaap-eps-019-beats-020-estimate-sales-195m-beat-182m-estimate
InspireMD Q4 2024 GAAP EPS $(0.19) Beats $...
03/12/2025 11:04:16

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by ...

earnings-scheduled-for-march-12-2025
Earnings Scheduled For March 12, 2025
03/12/2025 08:32:26

inspiremd-and-namsa-medtech-contract-research-organization-announced-strategic-outsourcing-partnership-to-conduct-cguardians-ii-pivotal-study-of-inspiremds-cguard-prime-80-cm-carotid-stent-system-for-use-in-transcarotid-artery-revascularization-procedures
InspireMD And Namsa Medtech Contract Resea...
02/13/2025 12:09:29

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION